FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to medicine and aims at treating phenylketonuria. What is declared is a dosage form containing a) phenylalanine-4-hydroxylase and/or phenylalanine ammonia-lyase and b) at least one peptidase, wherein a), b) or both a) and b) have an enteric coating.
EFFECT: declared invention is effective in treating phenylketonuria.
13 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAMTERENE OR NOLATREXED FOR USE IN TREATING PHENYLKETONURIA | 2020 |
|
RU2815197C2 |
| SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2328504C2 |
| COMPOSITIONS OF PROKARYOTIC PHENYLALANINE-AMMONIA-LYASE AND METHOD OF CANCER TREATMENT WITH APPLICATION OF SUCH COMPOSITIONS | 2008 |
|
RU2553343C2 |
| PHENYLALANINE-FREE PROTEIN FOR TREATMENT OF PKU | 2017 |
|
RU2764796C2 |
| LIQUID NUTRITIONAL COMPOSITION COMPRISING FREE AMINO ACIDS | 2013 |
|
RU2598630C2 |
| SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2263678C2 |
| METHODS OF MITOCHONDRIAL MALFUNCTIONS | 2000 |
|
RU2394580C2 |
| METHOD FOR TREATING MITOCHONDRIAL DISORDERS | 2000 |
|
RU2268732C2 |
| ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS FOR REGULATING IRON METABOLISM | 2013 |
|
RU2684216C2 |
| PHARMACEUTICAL FORM FOR DRUG ADMINISTRATION IN COLON, METHOD OF DRUG ADMINISTRATION AND A METHOD OF PREPARING MATRICES FOR THIS FORM | 1991 |
|
RU2113221C1 |
